Approvals (Drugs@FDA)

IBTROZI

NUVATION · TALETRECTINIB ADIPATE

NDA219713Drug (NDA)Prescription
Open FDA's page for this record
Application number
NDA219713
Sponsor name
NUVATION
Submissions
  1. Submission type
    SUPPL
    Submission number
    4
    Submission status
    AP
    Submission status date
    20260916
    Review priority
    STANDARD
    Submission class code
    EFFICACY
    Submission class code description
    Efficacy
    Submission property type
    1. Code
      Orphan
    Application docs
    1. ID
      87216
      Url
      https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/219713Orig1s004ltr.pdf
      Date
      20260921
      Type
      Letter
    2. ID
      87238
      Url
      https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/219713s004lbl.pdf
      Date
      20260922
      Type
      Label
  2. Submission type
    ORIG
    Submission number
    1
    Submission status
    AP
    Submission status date
    20250611
    Review priority
    PRIORITY
    Submission class code
    TYPE 1
    Submission class code description
    Type 1 - New Molecular Entity
    Submission property type
    1. Code
      Orphan
    Application docs
    1. ID
      82556
      Url
      https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/219713Orig1s000ltr.pdf
      Date
      20250612
      Type
      Letter
    2. ID
      82557
      Url
      http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/219713s000lbl.pdf
      Date
      20250612
      Type
      Label
    3. ID
      82724
      Url
      https://www.accessdata.fda.gov/drugsatfda_docs/nda/2025/219713Orig1s000TOC.html
      Date
      20250702
      Type
      Review
Products
  1. Product number
    001
    Reference drug
    Yes
    Brand name
    IBTROZI
    Reference standard
    Yes
    Dosage form
    CAPSULE
    Route
    ORAL
    Marketing status
    Prescription
    Active ingredients
    1. Name
      TALETRECTINIB ADIPATE
      Strength
      EQ 200MG BASE
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.